We discuss the new partnership between Velocity Clinical Research and Palantir, recent stock market bumps in the CRO sector, and the ongoing challenges facing US clinical trials. Plus, we chat about global research trends, upcoming conferences, and invite your questions for future episodes. Tune in for candid commentary, industry insights, and a bit of fun along the way!